vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and HA Sustainable Infrastructure Capital, Inc. (HASI). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $114.8M, roughly 1.5× HA Sustainable Infrastructure Capital, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 13.3%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 4.2%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.
ESPR vs HASI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $114.8M |
| Net Profit | — | $-53.8M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | -57.4% |
| Net Margin | — | -46.8% |
| Revenue YoY | 143.7% | 13.3% |
| Net Profit YoY | — | -176.7% |
| EPS (diluted) | $0.32 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $114.8M | ||
| Q3 25 | $87.3M | $103.1M | ||
| Q2 25 | $82.4M | $85.7M | ||
| Q1 25 | $65.0M | $96.9M | ||
| Q4 24 | $69.1M | $101.3M | ||
| Q3 24 | $51.6M | $82.0M | ||
| Q2 24 | $73.8M | $94.5M | ||
| Q1 24 | $137.7M | $105.8M |
| Q4 25 | — | $-53.8M | ||
| Q3 25 | $-31.3M | $83.3M | ||
| Q2 25 | $-12.7M | $98.4M | ||
| Q1 25 | $-40.5M | $56.6M | ||
| Q4 24 | — | $70.1M | ||
| Q3 24 | $-29.5M | $-19.6M | ||
| Q2 24 | $-61.9M | $26.5M | ||
| Q1 24 | $61.0M | $123.0M |
| Q4 25 | 50.6% | -57.4% | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | -34.0% | 84.7% | ||
| Q4 24 | -6.4% | 90.9% | ||
| Q3 24 | -31.0% | -32.1% | ||
| Q2 24 | 3.5% | 39.5% | ||
| Q1 24 | 52.5% | — |
| Q4 25 | — | -46.8% | ||
| Q3 25 | -35.9% | 80.8% | ||
| Q2 25 | -15.4% | 114.9% | ||
| Q1 25 | -62.2% | 58.4% | ||
| Q4 24 | — | 69.2% | ||
| Q3 24 | -57.2% | -23.9% | ||
| Q2 24 | -83.9% | 28.1% | ||
| Q1 24 | 44.3% | 116.3% |
| Q4 25 | $0.32 | $-0.38 | ||
| Q3 25 | $-0.16 | $0.61 | ||
| Q2 25 | $-0.06 | $0.74 | ||
| Q1 25 | $-0.21 | $0.44 | ||
| Q4 24 | $-0.14 | $0.58 | ||
| Q3 24 | $-0.15 | $-0.17 | ||
| Q2 24 | $-0.33 | $0.23 | ||
| Q1 24 | $0.34 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $110.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $2.7B |
| Total Assets | $465.9M | $8.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $110.2M | ||
| Q3 25 | $92.4M | $301.8M | ||
| Q2 25 | $86.1M | $86.5M | ||
| Q1 25 | $114.6M | $67.4M | ||
| Q4 24 | $144.8M | $129.8M | ||
| Q3 24 | $144.7M | $44.1M | ||
| Q2 24 | $189.3M | $145.7M | ||
| Q1 24 | $226.6M | $61.4M |
| Q4 25 | $-302.0M | $2.7B | ||
| Q3 25 | $-451.4M | $2.7B | ||
| Q2 25 | $-433.5M | $2.6B | ||
| Q1 25 | $-426.2M | $2.5B | ||
| Q4 24 | $-388.7M | $2.4B | ||
| Q3 24 | $-370.2M | $2.3B | ||
| Q2 24 | $-344.2M | $2.3B | ||
| Q1 24 | $-294.3M | $2.3B |
| Q4 25 | $465.9M | $8.2B | ||
| Q3 25 | $364.0M | $8.2B | ||
| Q2 25 | $347.1M | $7.6B | ||
| Q1 25 | $324.0M | $7.5B | ||
| Q4 24 | $343.8M | $7.1B | ||
| Q3 24 | $314.1M | $6.7B | ||
| Q2 24 | $352.3M | $6.7B | ||
| Q1 24 | $373.1M | $6.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $167.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $167.3M | ||
| Q3 25 | $-4.3M | $-121.8M | ||
| Q2 25 | $-31.4M | $79.6M | ||
| Q1 25 | $-22.6M | $-37.1M | ||
| Q4 24 | $-35.0M | $5.9M | ||
| Q3 24 | $-35.3M | $21.9M | ||
| Q2 24 | $-7.2M | $-24.8M | ||
| Q1 24 | $53.8M | $20.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | -0.66× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.94× | ||
| Q1 24 | 0.88× | 0.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
HASI
Segment breakdown not available.
